{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:23:53Z","timestamp":1795209833178,"version":"4.10.3"},"reference-count":261,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002641","name":"Konkuk University","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100002641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psoriasis is a chronic inflammatory skin disease driven by dysregulated immune responses and aberrant keratinocyte (KC) proliferation, with a profound impact on patient quality of life. Emerging evidence highlights extracellular vesicles (EVs) as promising therapeutic candidates in regenerative medicine, offering new avenues for psoriasis management. This review provides a critical overview of psoriasis pathophysiology and evaluates the mechanistic basis of EV-based therapies, emphasizing their immunomodulatory capacity to restore immune homeostasis. We synthesize findings from preclinical studies, demonstrating the therapeutic potential of EVs derived from diverse cellular sources, including their ability to attenuate inflammation, regulate immune responses, enhance wound repair, and modulate KC function. Finally, we explore future directions aimed at optimizing EV therapeutic efficacy and translating these findings into clinical practice. Collectively, this review underscores EVs as a novel, targeted, and cell-free therapeutic strategy with the potential to transform psoriasis treatment.<\/jats:p>","DOI":"10.3390\/ijms262110297","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:14:02Z","timestamp":1761182042000},"page":"10297","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Therapeutic Potential of Extracellular Vesicles in Psoriasis Treatment: Mechanisms, Applications, and Prospects"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3873-9903","authenticated-orcid":false,"given":"Ahmed","family":"Abdal Dayem","sequence":"first","affiliation":[{"name":"Stem Cell and Regenerative Biotechnology Major, School of Advanced Biotechnology, College of Institute of Science and Technology, Molecular & Cellular Reprogramming Center, Institute of Advanced Regenerative Science, Institute of Health, Aging & Society, Konkuk University, Seoul 05029, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeongjin","family":"Song","sequence":"additional","affiliation":[{"name":"Stem Cell and Regenerative Biotechnology Major, School of Advanced Biotechnology, College of Institute of Science and Technology, Molecular & Cellular Reprogramming Center, Institute of Advanced Regenerative Science, Institute of Health, Aging & Society, Konkuk University, Seoul 05029, Republic of Korea"},{"name":"R&D Team, StemExOne Co., Ltd., 102, 19, Achasan-ro 5gil, Seongdong-gu, Seoul 04793, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhyeok","family":"Park","sequence":"additional","affiliation":[{"name":"Stem Cell and Regenerative Biotechnology Major, School of Advanced Biotechnology, College of Institute of Science and Technology, Molecular & Cellular Reprogramming Center, Institute of Advanced Regenerative Science, Institute of Health, Aging & Society, Konkuk University, Seoul 05029, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6908-0932","authenticated-orcid":false,"given":"Ki-Heon","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Dermatology, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5456-255X","authenticated-orcid":false,"given":"Kyung Min","family":"Lim","sequence":"additional","affiliation":[{"name":"R&D Team, StemExOne Co., Ltd., 102, 19, Achasan-ro 5gil, Seongdong-gu, Seoul 04793, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejong","family":"Kim","sequence":"additional","affiliation":[{"name":"R&D Team, StemExOne Co., Ltd., 102, 19, Achasan-ro 5gil, Seongdong-gu, Seoul 04793, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwonwoo","family":"Song","sequence":"additional","affiliation":[{"name":"R&D Team, StemExOne Co., Ltd., 102, 19, Achasan-ro 5gil, Seongdong-gu, Seoul 04793, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0968-7932","authenticated-orcid":false,"given":"Ssang-Goo","family":"Cho","sequence":"additional","affiliation":[{"name":"Stem Cell and Regenerative Biotechnology Major, School of Advanced Biotechnology, College of Institute of Science and Technology, Molecular & Cellular Reprogramming Center, Institute of Advanced Regenerative Science, Institute of Health, Aging & Society, Konkuk University, Seoul 05029, Republic of Korea"},{"name":"R&D Team, StemExOne Co., Ltd., 102, 19, Achasan-ro 5gil, Seongdong-gu, Seoul 04793, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Update aetiopathogenesis and treatment of psoriasis: A literature review","volume":"4","author":"Chen","year":"2023","journal-title":"J. Dermatol. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: A systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kimmel, G.W., and Lebwohl, M. (2018). Psoriasis: Overview and Diagnosis. Evidence-Based Psoriasis, Springer International Publishing.","DOI":"10.1007\/978-3-319-90107-7_1"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jaad.2013.12.018","article-title":"Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey","volume":"70","author":"Lebwohl","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/bjd\/ljad141","article-title":"Electronic screening for mental illness in patients with psoriasis","volume":"189","author":"Bechman","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.genhosppsych.2022.01.006","article-title":"Associations between psoriasis and mental illness: An update for clinicians","volume":"75","author":"Hedemann","year":"2022","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00403-024-03112-y","article-title":"Association between psoriasis and obsessive-compulsive disorder: A case-control study in the All of Us research program","volume":"316","author":"Craver","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41380-024-02792-2","article-title":"Comorbid health outcomes in patients with schizophrenia: An umbrella review of systematic reviews and meta-analyses","volume":"30","author":"Lee","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nrl.2020.12.007","article-title":"Association between psoriasis and dementia: A systematic review","volume":"39","author":"Zhao","year":"2024","journal-title":"Neurologia"},{"key":"ref_12","first-page":"280","article-title":"The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey","volume":"137","author":"Krueger","year":"2001","journal-title":"Arch. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/09546634.2015.1044492","article-title":"A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis","volume":"27","author":"Pariser","year":"2016","journal-title":"J. Dermatol. Treat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bugaut, H., and Aractingi, S. (2021). Major role of the IL17\/23 axis in psoriasis supports the development of new targeted therapies. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.621956"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 Signaling Pathway and the Treatment of Psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jdv.14433","article-title":"The role of IL-23 and the IL-23\/T(H) 17 immune axis in the pathogenesis and treatment of psoriasis","volume":"31","author":"Girolomoni","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s00018-020-03726-1","article-title":"Immune responses and therapeutic options in psoriasis","volume":"78","author":"Afonina","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Liu, T., Li, S., Ying, S., Tang, S., Ding, Y., Li, Y., Qiao, J., and Fang, H. (2020). The IL-23\/IL-17 pathway in inflammatory skin diseases: From bench to bedside. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.594735"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e142067","DOI":"10.1172\/jci.insight.142067","article-title":"Cytokinocytes: The diverse contribution of keratinocytes to immune responses in skin","volume":"5","author":"Jiang","year":"2020","journal-title":"JCI Insight"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Piipponen, M., Li, D., and Land\u00e9n, N.X. (2020). The Immune Functions of Keratinocytes in Skin Wound Healing. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228790"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14712598.2015.1084284","article-title":"Targeting the IL-23\/IL-17 axis for the treatment of psoriasis and psoriatic arthritis","volume":"15","author":"Alunno","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Iuliano, M., Grimaldi, L., Rosa, P., Scibetta, S., Bernardini, N., Proietti, I., Tolino, E., Skroza, N., Potenza, C., and Mangino, G. (2024). Extracellular vescicles in psoriasis: From pathogenesis to possible roles in therapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1360618"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ced\/llac108","article-title":"Extracellular vesicles: A comprehensive review of their roles as biomarkers and potential therapeutics in psoriasis and psoriatic arthritis","volume":"48","author":"Born","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12967-024-05030-z","article-title":"Keratinocyte-derived circulating microRNAs in extracellular vesicles: A novel biomarker of psoriasis severity and potential therapeutic target","volume":"22","author":"Park","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/biosci\/biv084","article-title":"Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study","volume":"65","author":"Zaborowski","year":"2015","journal-title":"Bioscience"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e13383","DOI":"10.1111\/aji.13383","article-title":"Immunomodulatory properties of extracellular vesicles in the dialogue between placental and immune cells","volume":"85","author":"Favaro","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"109237","DOI":"10.1016\/j.clim.2023.109237","article-title":"Extracellular vesicles of immune cells; immunomodulatory impacts and therapeutic potentials","volume":"248","author":"Mahmoudi","year":"2023","journal-title":"Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcyt.2023.03.015","article-title":"A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis","volume":"25","author":"Lai","year":"2023","journal-title":"Cytotherapy"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e15001","DOI":"10.1111\/exd.15001","article-title":"Extracellular vesicles from keratinocytes and other skin-related cells in psoriasis: A review","volume":"33","author":"Qi","year":"2024","journal-title":"Exp. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e20240011","DOI":"10.1002\/INMD.20240011","article-title":"Extracellular vesicles in skin health, diseases, and aging","volume":"2","author":"Wang","year":"2024","journal-title":"Interdiscip. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/cbe.4c00122","article-title":"Engineered Extracellular Vesicles as a New Class of Nanomedicine","volume":"2","author":"Wen","year":"2025","journal-title":"Chem. Bio Eng."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"de Jong, B., Barros, E.R., Hoenderop, J.G.J., and Rigalli, J.P. (2020). Recent Advances in Extracellular Vesicles as Drug Delivery Systems and Their Potential in Precision Medicine. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12111006"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15283\/ijsc24089","article-title":"Efficient Treatment of Psoriasis Using Conditioned Media from Mesenchymal Stem Cell Spheroids Cultured to Produce Transforming Growth Factor-\u03b21-Enriched Small-Sized Extracellular Vesicles","volume":"17","author":"Song","year":"2024","journal-title":"Int. J. Stem Cells"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3899\/jrheum.170516","article-title":"Epidemiology and Medication Pattern Change of Psoriatic Diseases in Taiwan from 2000 to 2013: A Nationwide, Population-based Cohort Study","volume":"45","author":"Wei","year":"2018","journal-title":"J. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: A brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/jamadermatol.2017.2103","article-title":"Psoriasis","volume":"153","author":"Armstrong","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","article-title":"Atopic dermatitis and psoriasis: Two different immune diseases or one spectrum?","volume":"48","author":"Krueger","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhang, B., Yin, Y., Lai, R.C., and Lim, S.K. (2014). Immunotherapeutic potential of extracellular vesicles. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00518"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on psoriasis immunopathogenesis and targeted immunotherapy","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1365-4632.2010.04570.x","article-title":"The role of drugs in the induction and\/or exacerbation of psoriasis","volume":"49","author":"Basavaraj","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(08)81761-6","article-title":"Angiotensin-converting enzyme inhibitors as possible exacerbating drugs in psoriasis","volume":"28","author":"Gilleaudeau","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2133.2002.48848.x","article-title":"Sartans, angiotensin II receptor antagonists, can induce psoriasis","volume":"147","author":"Grosshans","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1365-2133.2008.08563.x","article-title":"Association between \u03b2-blockers, other antihypertensive drugs and psoriasis: Population-based case\u2013control study","volume":"158","author":"Brauchli","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cpm.2016.02.004","article-title":"Psoriasis: Pathogenesis, assessment, and therapeutic update","volume":"33","author":"Schleicher","year":"2016","journal-title":"Clin. Podiatr. Med. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"K\u00f5ks, S., Keermann, M., Reimann, E., Prans, E., Abram, K., Silm, H., K\u00f5ks, G., and Kingo, K. (2016). Psoriasis-specific RNA isoforms identified by RNA-seq analysis of 173,446 transcripts. Front. Med., 3.","DOI":"10.3389\/fmed.2016.00046"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/CM9.0000000000001243","article-title":"An update on the role of long non-coding RNAs in psoriasis","volume":"134","author":"Song","year":"2021","journal-title":"Chin. Med. J."},{"key":"ref_53","first-page":"4011","article-title":"Construction of a lncRNA-miRNA-mRNA network to determine the regulatory roles of lncRNAs in psoriasis","volume":"18","author":"Zhou","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jid.2019.08.437","article-title":"Psoriasis: Past, present, and future","volume":"139","author":"Billi","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1346-8138.14139","article-title":"Pathogenesis of psoriasis and development of treatment","volume":"45","author":"Ogawa","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"13241","DOI":"10.1096\/fj.201900642R","article-title":"Keratinocyte exosomes activate neutrophils and enhance skin inflammation in psoriasis","volume":"33","author":"Jiang","year":"2019","journal-title":"FASEB J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1529-8019.2006.00082.x","article-title":"Update on retinoid therapy of psoriasis in: An update on the use of retinoids in dermatology","volume":"19","year":"2006","journal-title":"Dermatol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/503821","article-title":"Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene","volume":"78","author":"Nair","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15382","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/jid.2009.319","article-title":"Molecular dissection of psoriasis: Integrating genetics and biology","volume":"130","author":"Elder","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"Lowes","year":"2013","journal-title":"Trends Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/15548627.2020.1725381","article-title":"Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation","volume":"17","author":"Wang","year":"2021","journal-title":"Autophagy"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: From keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12964-023-01381-0","article-title":"Triggers for the onset and recurrence of psoriasis: A review and update","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2009.05152.x","article-title":"Plasmacytoid dendritic cells: Key players in the initiation and regulation of immune responses","volume":"1183","author":"Lande","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Kamata, M., and Tada, Y. (2022). Dendritic cells and macrophages in the pathogenesis of psoriasis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.941071"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaad.2009.05.042","article-title":"A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis","volume":"62","author":"Bissonnette","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00403-021-02207-0","article-title":"Macrophages in dermatology: Pathogenic roles and targeted therapeutics","volume":"314","author":"Kuraitis","year":"2022","journal-title":"Arch. Dermatol. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s13238-018-0505-z","article-title":"IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis","volume":"9","author":"Hou","year":"2018","journal-title":"Protein Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00441-022-03616-x","article-title":"Human umbilical cord-derived mesenchymal stem cells ameliorate psoriasis-like dermatitis by suppressing IL-17-producing \u03b3\u03b4 T cells","volume":"388","author":"Chen","year":"2022","journal-title":"Cell Tissue Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","article-title":"IL-12 and IL-23: Master regulators of innate and adaptive immunity","volume":"202","author":"Langrish","year":"2004","journal-title":"Immunol. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/jid.2014.98","article-title":"IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing \u03b3\u03b4 T cells","volume":"134","author":"Yoshiki","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"10723","DOI":"10.1073\/pnas.1307569110","article-title":"Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice","volume":"110","author":"Wohn","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/mi.2015.65","article-title":"CD11c(+) monocyte\/macrophages promote chronic Helicobacter hepaticus-induced intestinal inflammation through the production of IL-23","volume":"9","author":"Arnold","year":"2016","journal-title":"Mucosal Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jaad.2013.10.043","article-title":"Specific targeting of interleukin-23p19 as effective treatment for psoriasis","volume":"70","author":"Levin","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","article-title":"Stat3 and Stat4 direct development of IL-17-secreting Th cells","volume":"178","author":"Mathur","year":"2007","journal-title":"J. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Chiricozzi, A., Nograles, K.E., Johnson-Huang, L.M., Fuentes-Duculan, J., Cardinale, I., Bonifacio, K.M., Gulati, N., Mitsui, H., Guttman-Yassky, E., and Suarez-Farinas, M. (2014). IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090284"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cei.13141","article-title":"Indirect co-cultures of healthy mesenchymal stem cells restore the physiological phenotypical profile of psoriatic mesenchymal stem cells","volume":"193","author":"Campanati","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-022-01059-y","article-title":"Human umbilical cord mesenchymal stem cells for psoriasis: A phase 1\/2a, single-arm study","volume":"7","author":"Cheng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jid.2020.07.009","article-title":"Small Extracellular Vesicles Containing miR-381-3p from Keratinocytes Promote T Helper Type 1 and T Helper Type 17 Polarization in Psoriasis","volume":"141","author":"Jiang","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1084\/jem.21213insight3","article-title":"An autoimmune \u201cattack\u201d on melanocytes triggers psoriasis and cellular hyperplasia","volume":"212","author":"Krueger","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"218","DOI":"10.15283\/ijsc18034","article-title":"Mesenchymal Stem Cells from the Wharton\u2019s Jelly of the Human Umbilical Cord: Biological Properties and Therapeutic Potential","volume":"12","author":"Marino","year":"2019","journal-title":"Int. J. Stem Cells"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Li, L., Lu, J., Liu, J., Wu, J., Zhang, X., Meng, Y., Wu, X., Tai, Z., Zhu, Q., and Chen, Z. (2023). Immune cells in the epithelial immune microenvironment of psoriasis: Emerging therapeutic targets. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1340677"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6961052","DOI":"10.1155\/2019\/6961052","article-title":"Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs)","volume":"2019","author":"Chen","year":"2019","journal-title":"Stem Cells Int."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Iwaszko, M., Bialy, S., and Bogunia-Kubik, K. (2021). Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis. Cells, 10.","DOI":"10.3390\/cells10113000"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Moniaga, C.S., Tominaga, M., and Takamori, K. (2021). The Pathology of Type 2 Inflammation-Associated Itch in Atopic Dermatitis. Diagnostics, 11.","DOI":"10.3390\/diagnostics11112090"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10753-023-01785-7","article-title":"Human Umbilical Cord-Derived Mesenchymal Stem Cells Alleviate Psoriasis Through TNF-\u03b1\/NF-\u03baB\/MMP13 Pathway","volume":"46","author":"Ren","year":"2023","journal-title":"Inflammation"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Cuesta-Gomez, N., Medina-Ruiz, L., Graham, G.J., and Campbell, J.D.M. (2023). IL-6 and TGF-\u03b2-Secreting Adoptively-Transferred Murine Mesenchymal Stromal Cells Accelerate Healing of Psoriasis-like Skin Inflammation and Upregulate IL-17A and TGF-\u03b2. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210132"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4161\/jkst.19918","article-title":"Infection-induced IL-10 and JAK-STAT: A review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes","volume":"1","author":"Carey","year":"2012","journal-title":"Jak-Stat"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Hovsepian, E., Penas, F., Siffo, S., Mirkin, G.A., and Goren, N.B. (2013). IL-10 inhibits the NF-\u03baB and ERK\/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079445"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10753-018-0895-3","article-title":"GDF11 Antagonizes Psoriasis-like Skin Inflammation via Suppression of NF-\u03baB Signaling Pathway","volume":"42","author":"Wang","year":"2019","journal-title":"Inflammation"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jid.2009.252","article-title":"A role for TGF\u03b2 signaling in the pathogenesis of psoriasis","volume":"130","author":"Han","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00018-025-05606-y","article-title":"SLPI controls neutrophil migration abilities and impacts neutrophil skin infiltration in experimental psoriasis","volume":"82","author":"Kwiecinska","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_104","first-page":"281","article-title":"Human umbilical cord blood-derived mesenchymal stem cells ameliorate psoriasis-like skin inflammation in mice","volume":"9","author":"Lee","year":"2017","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41419-022-05445-w","article-title":"Mesenchymal stem\/stromal cells primed by inflammatory cytokines alleviate psoriasis-like inflammation via the TSG-6-neutrophil axis","volume":"13","author":"Ding","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI27514","article-title":"CXCR2 ligands and G-CSF mediate PKC\u03b1-induced intraepidermal inflammation","volume":"116","author":"Cataisson","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"H468","DOI":"10.1152\/ajpheart.00491.2010","article-title":"Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1","volume":"300","author":"Lam","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-018-03925-2","article-title":"Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation","volume":"9","author":"Pircher","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Chiang, C.C., Cheng, W.J., Korinek, M., Lin, C.Y., and Hwang, T.L. (2019). Neutrophils in Psoriasis. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02376"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Neu, S.D., Strzepa, A., Martin, D., Sorci-Thomas, M.G., Pritchard, K.A., and Dittel, B.N. (2021). Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice. Antioxidants, 10.","DOI":"10.3390\/antiox10091338"},{"key":"ref_111","first-page":"1","article-title":"Mesenchymal stem cell licensing: Enhancing MSC function as a translational approach for the treatment of tendon injury","volume":"84","author":"Koch","year":"2023","journal-title":"Am. J. Vet. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.21037\/atm-21-5028","article-title":"Adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment for psoriasis: Results of a single-arm pilot trial","volume":"9","author":"Yao","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","article-title":"The secretion profile of mesenchymal stem cells and potential applications in treating human diseases","volume":"7","author":"Han","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Chen, L., Tredget, E.E., Wu, P.Y.G., and Wu, Y. (2024). Correction: Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0302417"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Pawitan, J.A. (2014). Prospect of stem cell conditioned medium in regenerative medicine. BioMed Res. Int., 2014.","DOI":"10.1155\/2014\/965849"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.yexcr.2010.02.026","article-title":"Mesenchymal stem cell-conditioned medium accelerates skin wound healing: An in vitro study of fibroblast and keratinocyte scratch assays","volume":"316","author":"Walter","year":"2010","journal-title":"Exp. Cell Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3109\/14653249.2012.706705","article-title":"Mesenchymal stromal cells of human umbilical cord Wharton\u2019s jelly accelerate wound healing by paracrine mechanisms","volume":"14","author":"Shohara","year":"2012","journal-title":"Cytotherapy"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"160","DOI":"10.59278\/cbs.v2i5.37","article-title":"Therapeutic Potential of Secretome-Derived Wharton\u2019s Jelly Mesenchymal Stem Cells in Psoriasis Vulgaris: A Case Study","volume":"2","author":"Azzahara","year":"2023","journal-title":"Int. J. Cell Biomed. Sci."},{"key":"ref_119","first-page":"8309103","article-title":"Mesenchymal stem cell conditioned media ameliorate psoriasis vulgaris: A case study","volume":"2019","author":"Seetharaman","year":"2019","journal-title":"Case Rep. Dermatol. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.35702\/Derm.10038","article-title":"JAK\/STAT Pathway in Psoriasis and Psoriatic Arthritis: Insights into Inflammation and Tissue Remodeling","volume":"5","author":"Misra","year":"2025","journal-title":"Dermis"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e2400621","DOI":"10.1002\/ardp.202400621","article-title":"Research progress on the pathogenesis of psoriasis and its small molecule inhibitors","volume":"358","author":"Xia","year":"2025","journal-title":"Arch. Der Pharm."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Hu, Q., Bian, Q., Rong, D., Wang, L., Song, J., Huang, H.-S., Zeng, J., Mei, J., and Wang, P.-Y. (2023). JAK\/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1110765"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: Autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/art.40447","article-title":"Augmented Th17 differentiation leads to cutaneous and Synovio-Entheseal inflammation in a novel model of psoriatic arthritis","volume":"70","author":"Yang","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jid.2016.06.009","article-title":"Keratinocyte-derived IL-17E contributes to inflammation in psoriasis","volume":"136","author":"Senra","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41419-025-07358-w","article-title":"S1PR3-driven positive feedback loop sustains STAT3 activation and keratinocyte hyperproliferation in psoriasis","volume":"16","author":"Lian","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.2147\/JIR.S380686","article-title":"TYK2 in immune responses and treatment of psoriasis","volume":"15","author":"Shang","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/ard-2023-223850","article-title":"Selectivity, efficacy and safety of JAKinibs: New evidence for a still evolving story","volume":"83","author":"Bonelli","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/apm.13221","article-title":"Role of IL-22 in homeostasis and diseases of the skin","volume":"130","author":"Lopez","year":"2022","journal-title":"Apmis"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4049\/jimmunol.2300094","article-title":"The World according to IL-9","volume":"211","author":"Pajulas","year":"2023","journal-title":"J. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Carmona-Rocha, E., Rusi\u00f1ol, L., and Puig, L. (2024). New and emerging oral\/topical small-molecule treatments for psoriasis. Pharmaceutics, 16.","DOI":"10.20944\/preprints202401.0800.v1"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4049\/jimmunol.1001001","article-title":"IL-23\u2013mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A","volume":"186","author":"Rizzo","year":"2011","journal-title":"J. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-\u03baB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Oeckinghaus, A., and Ghosh, S. (2009). The NF-\u03baB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol., 1.","DOI":"10.1101\/cshperspect.a000034"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/35070605","article-title":"IKK\u03b1 controls formation of the epidermis independently of NF-\u03baB","volume":"410","author":"Hu","year":"2001","journal-title":"Nature"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08830180802130319","article-title":"The two-faced NF-\u03baB in the skin","volume":"27","author":"Sur","year":"2008","journal-title":"Int. Rev. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Wan, F., and Lenardo, M.J. (2009). Specification of DNA binding activity of NF-\u03baB proteins. Cold Spring Harb. Perspect. Biol., 1.","DOI":"10.1101\/cshperspect.a000067"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wsbm.1331","article-title":"Signaling via the NF\u03baB system","volume":"8","author":"Mitchell","year":"2016","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-\u03baB, the first quarter-century: Remarkable progress and outstanding questions","volume":"26","author":"Hayden","year":"2012","journal-title":"Genes Dev."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.abb.2006.12.022","article-title":"BH3-only proteins trigger cytochrome c release, but how?","volume":"462","author":"Hacker","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12033","article-title":"NF-\u03baB: Roles and regulation in different CD4(+) T-cell subsets","volume":"252","author":"Oh","year":"2013","journal-title":"Immunol. Rev."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2017.07.007","article-title":"Psoriasis: A mixed autoimmune and autoinflammatory disease","volume":"49","author":"Liang","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.0022-202X.2005.23735.x","article-title":"Differential expression of phosphorylated NF-\u03baB\/RelA in normal and psoriatic epidermis and downregulation of NF-\u03baB in response to treatment with etanercept","volume":"124","author":"Lizzul","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/ijd.12050","article-title":"Role of NF-\u03baB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens","volume":"53","author":"Moorchung","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","article-title":"NF-\u03baB: An essential transcription factor in psoriasis","volume":"69","author":"Goldminz","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"32633","DOI":"10.1074\/jbc.M400642200","article-title":"Effects of tumor necrosis factor-\u03b1 (TNF \u03b1) in epidermal keratinocytes revealed using global transcriptional profiling","volume":"279","author":"Banno","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/intimm\/dxr110","article-title":"IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1\u03b2 by keratinocytes via the ROS-NLRP3-caspase-1 pathway","volume":"24","author":"Cho","year":"2012","journal-title":"Int. Immunol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.4049\/jimmunol.178.4.2229","article-title":"The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","volume":"178","author":"Sa","year":"2007","journal-title":"J. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.95.5.2307","article-title":"Alterations in NF-\u03baB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-\u03baB","volume":"95","author":"Seitz","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nature00820","article-title":"TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2","volume":"417","author":"Pasparakis","year":"2002","journal-title":"Nature"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-011-0818-1","article-title":"Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: A novel Boswellia serrata extract","volume":"354","author":"Sengupta","year":"2011","journal-title":"Mol. Cell Biochem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature03963","article-title":"Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins","volume":"437","author":"Zenz","year":"2005","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Li, Q., Ke, F., Zhang, W., Shen, X., Xu, Q., Wang, H., Yu, X.Z., Leng, Q., and Wang, H. (2011). Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016483"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/14740338.2023.2218086","article-title":"Bimekizumab treatment in patients with moderate to severe plaque psoriasis: A drug safety evaluation","volume":"22","author":"Ruggiero","year":"2023","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1358\/dot.2023.59.3.3419557","article-title":"Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis","volume":"59","author":"Simopoulou","year":"2023","journal-title":"Drugs Today"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Deng, Z., Wang, S., Wu, C., and Wang, C. (2023). IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1124628"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Eshwar, V., Kamath, A., Shastry, R., Shenoy, A.K., and Kamath, P. (2022). A Review of the Safety of Interleukin-17A Inhibitor Secukinumab. Pharmaceuticals, 15.","DOI":"10.3390\/ph15111365"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: From bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1517\/14712598.2016.1132695","article-title":"Ixekizumab: A new anti-IL-17A monoclonal antibody therapy for moderate-to severe plaque psoriasis","volume":"16","author":"Blauvelt","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Dainichi, T., Matsumoto, R., Mostafa, A., and Kabashima, K. (2019). Immune Control by TRAF6-Mediated Pathways of Epithelial Cells in the EIME (Epithelial Immune Microenvironment). Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01107"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Wang, J., Wang, C., Liu, L., Hong, S., Ru, Y., Sun, X., Chen, J., Zhang, M., Lin, N., and Li, B. (2023). Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: A systematic scoping review. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.993057"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(03)00203-X","article-title":"Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia","volume":"215","author":"Li","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.det.2014.09.002","article-title":"The immunopathogenesis of psoriasis","volume":"33","author":"Kim","year":"2015","journal-title":"Dermatol. Clin."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Piskin, G., de Boer, O.J., van der Loos, C.M., Teeling, P., Bos, J.D., and Teunissen, M.B. (2010). Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0014108"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-med-042915-103905","article-title":"Highly effective new treatments for psoriasis target the IL-23\/Type 17 T cell autoimmune axis","volume":"68","author":"Kim","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Chen, Y., Liu, H., He, Y., Yang, B., Lu, W., and Dai, Z. (2025). Roles for Exosomes in the Pathogenesis, Drug Delivery and Therapy of Psoriasis. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17010051"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Zhang, B., Lai, R.C., Sim, W.K., Choo, A.B.H., Lane, E.B., and Lim, S.K. (2021). Topical Application of Mesenchymal Stem Cell Exosomes Alleviates the Imiquimod Induced Psoriasis-Like Inflammation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020720"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1759720X19883973","DOI":"10.1177\/1759720X19883973","article-title":"Balancing benefits and risks in the era of biologics","volume":"11","author":"Adami","year":"2019","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/jir.2021.0146","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate psoriasis-like skin inflammation","volume":"42","author":"Zhang","year":"2022","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.2147\/CCID.S439760","article-title":"Adipose-derived stem cell exosomes alleviate psoriasis serum exosomes-induced inflammation by regulating autophagy and redox status in keratinocytes","volume":"16","author":"Kim","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Zhang, W., Lin, J., Shi, P., Su, D., Cheng, X., Yi, W., Yan, J., Chen, H., and Cheng, F. (2022). Small extracellular vesicles derived from MSCs have immunomodulatory effects to enhance delivery of ASO-210 for psoriasis treatment. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.842813"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2106265","DOI":"10.1002\/adma.202106265","article-title":"Mesenchymal stem cell-derived extracellular vesicles with high PD-L1 expression for autoimmune diseases treatment","volume":"34","author":"Xu","year":"2022","journal-title":"Adv. Mater."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e12361","DOI":"10.1002\/jev2.12361","article-title":"Plant exosomes fused with engineered mesenchymal stem cell-derived nanovesicles for synergistic therapy of autoimmune skin disorders","volume":"12","author":"Huang","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"122915","DOI":"10.1016\/j.lfs.2024.122915","article-title":"The safety and efficacy of adipose tissue-derived exosomes in treating mild to moderate plaque psoriasis: A clinical study","volume":"353","author":"Meybodi","year":"2024","journal-title":"Life Sci."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Rodrigues, S.C., Cardoso, R.M., Freire, P.C., Gomes, C.F., Duarte, F.V., Neves, R.P.d., and Sim\u00f5es-Correia, J. (2021). Immunomodulatory properties of umbilical cord blood-derived small extracellular vesicles and their therapeutic potential for inflammatory skin disorders. Int. J. Mol. Sci., 22.","DOI":"10.1101\/2021.08.06.455399"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.jid.2024.06.1280","article-title":"The Central Roles of Keratinocytes in Coordinating Skin Immunity","volume":"144","author":"Simmons","year":"2024","journal-title":"J. Investig. Dermatol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.3892\/mmr.2017.7492","article-title":"A novel non-contact communication between human keratinocytes and T cells: Exosomes derived from keratinocytes support superantigen-induced proliferation of resting T cells","volume":"16","author":"Cai","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Than, U.T., Guanzon, D., Broadbent, J.A., Leavesley, D.I., Salomon, C., and Parker, T.J. (2018). Differential expression of keratinocyte-derived extracellular vesicle mirnas discriminate exosomes from apoptotic bodies and microvesicles. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00535"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/exd.14015","article-title":"Interleukin-17A affects extracellular vesicles release and cargo in human keratinocytes","volume":"28","author":"Mangino","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Kim, H.R., Lee, S.Y., You, G.E., Park, C.W., Kim, H.O., and Chung, B.Y. (2023). Exosomes released by environmental pollutant-stimulated Keratinocytes\/PBMCs can trigger psoriatic inflammation in recipient cells via the AhR signaling pathway. Front. Mol. Biosci., 10.","DOI":"10.3389\/fmolb.2023.1324692"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11095-023-03648-0","article-title":"Keratinocyte exosomes for topical delivery of tofacitinib in treatment of psoriasis: An in vitro\/in vivo study in animal model of psoriasis","volume":"41","author":"Dehghani","year":"2024","journal-title":"Pharm. Res."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/exd.12230","article-title":"Immunostimulatory activity of murine keratinocyte-derived exosomes","volume":"22","author":"Kotzerke","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/jcb.21774","article-title":"Primary human keratinocytes externalize stratifin protein via exosomes","volume":"104","author":"Morse","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1038\/jid.2015.320","article-title":"Keratinocyte microvesicles regulate the expression of multiple genes in dermal fibroblasts","volume":"135","author":"Huang","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.7150\/thno.89180","article-title":"Keratinocyte-to-macrophage communication exacerbate psoriasiform dermatitis via LRG1-enriched extracellular vesicles","volume":"14","author":"Jiang","year":"2024","journal-title":"Theranostics"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"e15798","DOI":"10.7717\/peerj.15798","article-title":"Vitamin D receptor-deficient keratinocytes-derived exosomal miR-4505 promotes the macrophage polarization towards the M1 phenotype","volume":"11","author":"Sun","year":"2023","journal-title":"PeerJ"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2220445","DOI":"10.1080\/09546634.2023.2220445","article-title":"Engineering extracellular vesicles with macrophage membrane fusion for ameliorating imiquimod-induced psoriatic skin inflammation","volume":"34","author":"Wang","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0362-8","article-title":"Apoptotic cell-derived exosomes: Messages from dying cells","volume":"52","author":"Kakarla","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Wei, H., Chen, Q., Lin, L., Sha, C., Li, T., Liu, Y., Yin, X., Xu, Y., Chen, L., and Gao, W. (2021). Regulation of exosome production and cargo sorting. Int. J. Biol. Sci., 17.","DOI":"10.7150\/ijbs.53671"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.7150\/thno.45488","article-title":"Extracellular vesicles in inflammatory skin disorders: From pathophysiology to treatment","volume":"10","author":"Shao","year":"2020","journal-title":"Theranostics"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1096\/fj.201802090RR","article-title":"Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes","volume":"33","author":"Shao","year":"2019","journal-title":"FASEB J."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"103260","DOI":"10.1016\/j.autrev.2022.103260","article-title":"Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges","volume":"22","author":"Fang","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e15375","DOI":"10.1111\/dth.15375","article-title":"Pharmacoeconomic study of biologics for psoriasis treatment based on real-world drug survival","volume":"35","author":"Saisyo","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Iannone, L.F., Bennardo, L., Palleria, C., Roberti, R., De Sarro, C., Naturale, M.D., Dastoli, S., Donato, L., Manti, A., and Valenti, G. (2020). Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241575"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Witwer","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Tang, B., Bi, Y., Zheng, X., Yang, Y., Huang, X., Yang, K., Zhong, H., Han, L., Lu, C., and Chen, H. (2024). The Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16121586"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Paolino, G., Buratta, S., Mercuri, S.R., Pellegrino, R.M., Urbanelli, L., Emiliani, C., Bertuccini, L., Iosi, F., Huber, V., and Brianti, P. (2022). Lipidic profile changes in exosomes and microvesicles derived from plasma of monoclonal antibody-treated psoriatic patients. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.923769"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0223-5","article-title":"Extracellular vesicle-based therapeutics: Natural versus engineered targeting and trafficking","volume":"51","author":"Murphy","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.tcm.2020.08.003","article-title":"Experimental limitations of extracellular vesicle-based therapies for the treatment of myocardial infarction","volume":"31","author":"Kennedy","year":"2021","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Lu, W., Zhang, J., Wu, Y., Sun, W., Jiang, Z., and Luo, X. (2023). Engineered NF-\u03baB siRNA-encapsulating exosomes as a modality for therapy of skin lesions. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1109381"},{"key":"ref_209","first-page":"809","article-title":"Tumor-derived PD-L1+ exosomes with natural inflammation tropism for psoriasis-targeted treatment","volume":"34","author":"Jia","year":"2023","journal-title":"Bioconjugate Chem."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis\u2014Current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2410067","DOI":"10.1002\/advs.202410067","article-title":"Engineered Mesenchymal Stem Cell-Derived Extracellular Vesicles Scavenge Self-Antigens for Psoriasis Therapy via Modulating Metabolic and Immunological Disorders","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jconrel.2023.08.059","article-title":"Ultraviolet B radiation-induced JPH203-loaded keratinocyte extracellular vesicles exert etiological interventions for psoriasis therapy","volume":"362","author":"Jiang","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13046-025-03403-w","article-title":"Harnessing engineered extracellular vesicles for enhanced therapeutic efficacy: Advancements in cancer immunotherapy","volume":"44","author":"Gong","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"108282","DOI":"10.1016\/j.isci.2023.108282","article-title":"Engineered Extracellular Vesicles: A potential treatment for regeneration","volume":"26","author":"Cheng","year":"2023","journal-title":"Iscience"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"e12458","DOI":"10.1002\/jev2.12458","article-title":"A systematic review and meta-analysis of clinical trials assessing safety and efficacy of human extracellular vesicle-based therapy","volume":"13","author":"Derdelinckx","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Thakur, A., and Rai, D. (2024). Global requirements for manufacturing and validation of clinical grade extracellular vesicles. J. Liq. Biopsy, 6.","DOI":"10.1016\/j.jlb.2024.100278"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Lei, X., Ring, S., Jin, S., Singh, S., and Mahnke, K. (2025). Extracellular Vesicles and Their Role in Skin Inflammatory Diseases: From Pathogenesis to Therapy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26083827"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jcyt.2025.01.007","article-title":"A phase 1, open-label study to determine safety and tolerability of the topical application of mesenchymal stem\/stromal cell (MSC) exosome ointment to treat psoriasis in healthy volunteers","volume":"27","author":"Chandran","year":"2025","journal-title":"Cytotherapy"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archderm.143.2.239","article-title":"National Psoriasis Foundation clinical consensus on disease severity","volume":"143","author":"Pariser","year":"2007","journal-title":"Arch. Dermatol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","article-title":"Joint AAD\u2013NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures","volume":"84","author":"Elmets","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate to severe psoriasis: A European consensus","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaad.2019.08.026","article-title":"Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council","volume":"82","author":"Strober","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"e70041","DOI":"10.1111\/srt.70041","article-title":"A comparison of the safety and efficacy of tapinarof and roflumilast topical therapies in the management of mild-to-moderate plaque psoriasis","volume":"30","author":"Ghani","year":"2024","journal-title":"Ski. Res. Technol."},{"key":"ref_224","first-page":"e19182","article-title":"An update on narrowband ultraviolet B therapy for the treatment of skin diseases","volume":"13","author":"Myers","year":"2021","journal-title":"Cureus"},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Elsisi, A.E., Abu-Risha, S.E.-S., Alkabbani, M.A., Ramadan, L.A., and Sokar, S.S. (2025). Balancing efficacy and hepatotoxicity: A comprehensive review of oral medications in psoriasis management. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol., 1\u201330.","DOI":"10.1007\/s00210-025-04334-1"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2174\/1570159X21666230216095938","article-title":"Current Strategies for Promoting the Large-scale Production of Exosomes","volume":"21","author":"Qu","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Thippabhotla, S., Zhong, C., and He, M. (2019). 3D cell culture stimulates the secretion of in vivo like extracellular vesicles. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-49671-3"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s13770-018-0139-5","article-title":"Three-Dimensional Spheroid Culture Increases Exosome Secretion from Mesenchymal Stem Cells","volume":"15","author":"Kim","year":"2018","journal-title":"Tissue Eng. Regen. Med."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Yu, W., Li, S., Guan, X., Zhang, N., Xie, X., Zhang, K., and Bai, Y. (2022). Higher yield and enhanced therapeutic effects of exosomes derived from MSCs in hydrogel-assisted 3D culture system for bone regeneration. Biomater. Adv., 133.","DOI":"10.1016\/j.msec.2022.112646"},{"key":"ref_230","first-page":"10","article-title":"Genetic Determinants of High-Level Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus","volume":"62","author":"Borges","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s13287-020-02050-6","article-title":"Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo","volume":"11","author":"Cheng","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"567","DOI":"10.21873\/invivo.13475","article-title":"Exosome Secretion and Cellular Signaling Change in a Fabry Disease Cell Model Induced by Gene-silencing","volume":"38","author":"Park","year":"2024","journal-title":"In Vivo"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Salomon, C., Ryan, J., Sobrevia, L., Kobayashi, M., Ashman, K., Mitchell, M., and Rice, G.E. (2013). Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068451"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"20083","DOI":"10.1074\/jbc.M301642200","article-title":"Exosome release is regulated by a calcium-dependent mechanism in K562 cells","volume":"278","author":"Savina","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Wang, J., Bonacquisti, E.E., Brown, A.D., and Nguyen, J. (2020). Boosting the Biogenesis and Secretion of Mesenchymal Stem Cell-Derived Exosomes. Cells, 9.","DOI":"10.1101\/2020.02.08.940122"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Nair, A., Bu, J., Rawding, P.A., Do, S.C., Li, H., and Hong, S. (2021). Cytochalasin B Treatment and Osmotic Pressure Enhance the Production of Extracellular Vesicles (EVs) with Improved Drug Loading Capacity. Nanomaterials, 12.","DOI":"10.3390\/nano12010003"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Park, S., Kim, S., Lim, K., Shin, Y., Song, K., Kang, G.H., Kim, D.Y., Shin, H.C., and Cho, S.G. (2023). Thermostable Basic Fibroblast Growth Factor Enhances the Production and Activity of Human Wharton\u2019s Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216460"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/ijc.29664","article-title":"Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer","volume":"137","author":"Duijvesz","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Woud, W.W., Hesselink, D.A., Hoogduijn, M.J., Baan, C.C., and Boer, K. (2022). Direct detection of circulating donor-derived extracellular vesicles in kidney transplant recipients. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-26580-6"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"102121","DOI":"10.1016\/j.tranon.2024.102121","article-title":"A comprehensive review on recent advances in exosome isolation and characterization: Toward clinical applications","volume":"50","author":"Dilsiz","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1007\/s00216-022-04253-7","article-title":"Current status and outlook of advances in exosome isolation","volume":"414","author":"Liu","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Sidhom, K., Obi, P.O., and Saleem, A. (2020). A Review of Exosomal Isolation Methods: Is Size Exclusion Chromatography the Best Option?. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202007.0485.v2"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40580-025-00509-x","article-title":"Efficient methods of isolation and purification of extracellular vesicles","volume":"12","author":"Kim","year":"2025","journal-title":"Nano Converg."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Ljungstrom, M., and Oltra, E. (2025). Methods for Extracellular Vesicle Isolation: Relevance for Encapsulated miRNAs in Disease Diagnosis and Treatment. Genes, 16.","DOI":"10.20944\/preprints202502.0195.v1"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Garcovich, S., De Simone, C., Genovese, G., Berti, E., Cugno, M., and Marzano, A.V. (2019). Paradoxical skin reactions to biologics in patients with rheumatologic disorders. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00282"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jdv.16246","article-title":"Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: A systematic review","volume":"34","author":"Foulkes","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/PTT.S328575","article-title":"Biologics in psoriasis: Updated perspectives on long-term safety and risk management","volume":"12","author":"Yiu","year":"2022","journal-title":"Psoriasis Targets Ther."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjd.20517","article-title":"The promise and challenges of cell therapy for psoriasis","volume":"185","author":"Lwin","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Carrillo, D., Edwards, N., Arancibia-Altamirano, D., Ot\u00e1rola, F., Villarroel, C., Prieto, C.P., Villamizar-Sarmiento, M.G., Sauma, D., Valenzuela, F., and Lattus, J. (2023). Efficacy of stem cell secretome loaded in hyaluronate sponge for topical treatment of psoriasis. Bioeng. Transl. Med., 8.","DOI":"10.1002\/btm2.10443"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s13287-022-03091-9","article-title":"Topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis-like skin lesions in mice","volume":"13","author":"Yang","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13287-023-03472-8","article-title":"Biodistribution of mesenchymal stromal cell-derived extracellular vesicles administered during acute lung injury","volume":"14","author":"Tieu","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1210\/jc.2006-2865","article-title":"Determination of the elimination half-life of fibroblast growth factor-23","volume":"92","author":"Khosravi","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Ha, D.H., Kim, H.K., Lee, J., Kwon, H.H., Park, G.H., Yang, S.H., Jung, J.Y., Choi, H., Lee, J.H., and Sung, S. (2020). Mesenchymal Stem\/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration. Cells, 9.","DOI":"10.3390\/cells9051157"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"e70075","DOI":"10.1002\/ctm2.70075","article-title":"Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles: A focus on inflammatory bowel disease","volume":"14","author":"Suau","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Acevedo-S\u00e1nchez, V., Rodr\u00edguez-Hern\u00e1ndez, R.M., Aguilar-Ru\u00edz, S.R., Torres-Aguilar, H., Pina-Canseco, S., Ch\u00e1vez-Olmos, P., Garrido, E., Balti\u00e9rrez-Hoyos, R., and Romero-Tlalolini, M.A. (2025). Keratinocyte-derived extracellular vesicles induce macrophage polarization toward an M1-like phenotype. Biochem. Biophys. Res. Commun., 758.","DOI":"10.1016\/j.bbrc.2025.151659"},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Martinez-Arroyo, O., Ortega, A., Forner, M.J., and Cortes, R. (2022). Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14040733"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14348\/molcells.2022.2033","article-title":"Manufacturing therapeutic exosomes: From bench to industry","volume":"45","author":"Ahn","year":"2022","journal-title":"Mol. Cells"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"20417314251319474","DOI":"10.1177\/20417314251319474","article-title":"Extracellular vesicles: From large-scale production and engineering to clinical applications","volume":"16","author":"Wang","year":"2025","journal-title":"J. Tissue Eng."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jcyt.2024.05.018","article-title":"Minimal information for studies of extracellular vesicles 2023: Relevance to cell and gene therapies","volume":"26","author":"Witwer","year":"2024","journal-title":"Cytotherapy"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10297\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:24:49Z","timestamp":1761182689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":261,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262110297"],"URL":"https:\/\/doi.org\/10.3390\/ijms262110297","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}